These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Hyperuricemia and gout: therapeutic indications]. Pawlotsky Y Rev Prat; 1994 Jan; 44(2):206-9. PubMed ID: 8178077 [TBL] [Abstract][Full Text] [Related]
6. [How to treat hyperuricemia and gout attacks in compensated kidney failure?]. Gröbner W Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180 [No Abstract] [Full Text] [Related]
7. [Attempt at normalizing the uricemia in gout]. Piliaev VG Vrach Delo; 1980 Apr; (4):88-90. PubMed ID: 7385782 [No Abstract] [Full Text] [Related]
8. A new standard of care? Studies on febuxostat in the management of hyperuricemia with and without gout. Kamatani N; Hosoya T J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S11-2. PubMed ID: 21654264 [No Abstract] [Full Text] [Related]
9. [Hyperuricemia and gout. Case report]. Gröbner W; Walter-Sack I Dtsch Med Wochenschr; 2002 Feb; 127(5):207-9. PubMed ID: 11821992 [No Abstract] [Full Text] [Related]
10. Placebo-controlled double-blind dose-response study of the non-purine-selective xanthine oxidase inhibitor febuxostat (TMX-67) in patients with hyperuricemia (including gout patients) in japan: late phase 2 clinical study. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S35-43. PubMed ID: 21654268 [TBL] [Abstract][Full Text] [Related]
11. [GOUT AND HYPERTENSION]. Belovol AN; Knyazkova II; Miroshnykova IA Lik Sprava; 2015; (1-2):32-8. PubMed ID: 26118024 [TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled, double-blind study of the non-purine-selective xanthine oxidase inhibitor Febuxostat (TMX-67) in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S19-26. PubMed ID: 21654266 [TBL] [Abstract][Full Text] [Related]
14. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265 [TBL] [Abstract][Full Text] [Related]
15. Safety of urate-lowering therapies: managing the risks to gain the benefits. Keenan RT Rheum Dis Clin North Am; 2012 Nov; 38(4):663-80. PubMed ID: 23137576 [TBL] [Abstract][Full Text] [Related]
16. [Familial gout and nephropathy in a young woman. Report of one case]. Badilla A; Rojas C Rev Med Chil; 2001 Jun; 129(6):666-70. PubMed ID: 11510209 [TBL] [Abstract][Full Text] [Related]
17. The perils of nontreatment of hyperuricemia. Hoffman GS Cleve Clin J Med; 1997 Apr; 64(4):215. PubMed ID: 9105118 [No Abstract] [Full Text] [Related]
18. Multicenter, open-label study of long-term administration of febuxostat (TMX-67) in Japanese patients with hyperuricemia including gout. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S50-6. PubMed ID: 21654270 [TBL] [Abstract][Full Text] [Related]
19. An allopurinol-controlled, multicenter, randomized, open-label, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 2 exploratory clinical study. Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S44-9. PubMed ID: 21654269 [TBL] [Abstract][Full Text] [Related]
20. [Hyperuricemia: a laboratory finding needing treatment?]. Keller C Verh Dtsch Ges Inn Med; 1990; 96():188-92. PubMed ID: 2092438 [No Abstract] [Full Text] [Related] [Next] [New Search]